Please login to the form below

Not currently logged in
Email:
Password:

Novartis appoints Shaun Coughlin to lead its US biomedical research institute

The renowned academic joins as the pharma firm's global head of cardiovascular and metabolism

Shaun CoughlinNovartis has appointed Shaun Coughlin to head up its biomedical research institute based in Cambridge, Massachusetts, as its new global head of cardiovascular and metabolism.

He joins the pharma giant from the University of California San Francisco’s (UCSF) cardiovascular research centre, where he was previously a director. He has served UCSF for 33 years.

Talmadge King Jr, dean, school of medicine at USFC, said: “We are sad to lose on our most respected leaders, yet profoundly grateful for his decades of service and immeasurable contributions to our mission.

“Dr Coughlin is an outstanding example of the personal qualities that collectively have propelled UCSGF to the top.”

Coughlin is also a member of the National Academy of Scienes, the National Academy of Medicine and the American Academy of Arts & Scienes and has won numerous awards including Brisol-Myers Squibb’s Cardiovascular Research Award.

23rd August 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...
BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....

Infographics